以康替唑胺附加方案成功治疗合并急性血小板减少症的重症结核病患者：一例报告
Successful Treatment of Severe Tuberculosis With Contezolid Add-On Regimen in a Patient Complicated With Acute Thrombocytopenia: A Case Report.
作者信息
Zhou Liuqing, Wang Yimin, Zhou Jixue
机构信息
Department of Pulmonary Diseases Shanghai Donghai Senior Nursing Hospital Shanghai China.
Department of Tuberculosis, 905th Hospital of PLA Navy Naval Medical University Shanghai China.
出版信息
Clin Case Rep. 2024 Dec 18;12(12):e70001. doi: 10.1002/ccr3.70001. eCollection 2024 Dec.
Polypharmacy in managing severe tuberculosis patients usually poses a risk of adverse drug reactions. Contezolid is a new oxazolidinone antibiotic showing good in vitro and in vivo activity against . Contezolid add-on regimen shows promising efficacy and safety results in managing severe tuberculosis patients complicated with acute thrombocytopenia.
在管理重症结核病患者时，联合用药通常会带来药物不良反应的风险。康替唑胺是一种新型恶唑烷酮类抗生素，在体外和体内对……均显示出良好的活性。在管理合并急性血小板减少症的重症结核病患者时，康替唑胺附加方案显示出有前景的疗效和安全性结果。
Zotero 插件